Search Results - "Chelysheva, E Yu"

Changes in Bone Marrow Stromal Progenitor Cells in Patients with Hematoblastosis at the Onset of the Disease by Petinati, N. A., Shipounova, I. N., Fastova, E. A., Magomedova, A. U., Kravchenko, S. K., Chelysheva, E. Yu, Shukhov, O. A., Turkina, A. G., Sats, N. V., Drize, N. I., Parovichnikova, E. N., Savchenko, V. G.

“…Multipotent mesenchymal stromal cells (MSC) are the key regulators of hematopoiesis. We studied changes in MSC characteristics in patients with myeloid…”
Get full text

Multipotent Mesenchymal Stromal Cells in Patients with Chronic Myeloid Leukemia before Discontinuation of Tyrosine Kinase Inhibitors by Petinati, N. A., Petrova, A. N., Chelysheva, E. Yu, Shukhov, O. A., Bykova, A. V., Nemchenko, I. S., Sats, N. V., Turkina, A. G., Drize, N. I.

“…We analyzed changes in multipotent mesenchymal stromal cells of patients with chronic myeloid leukemia before discontinuation of tyrosine kinase inhibitors…”
Get full text

Results of following up patients with chronic myeloid leukemia and a deep molecular response without tyrosine kinase inhibitor therapy by Turkina, A G, Chelysheva, E Yu, Shuvaev, V A, Gusarova, G A, Bykova, A V, Shukhov, O A, Petrova, A N, Vakhrusheva, M V, Goryacheva, S R, Kolosova, L Yu, Krasikova, P S, Fominykh, M S, Martynkevich, I S, Abdullaev, A O, Sudarikov, A B, Savchenko, V G

“…To assess the results of following up patients with chronic myeloid leukemia (CML) and a deep molecular response (MR) without tyrosine kinase inhibitor (TKI)…”
Get full text

A rare case of myeloproliferative disease with t(8;13)(p11;q12) associated with eosinophilia and lymphadenopathy by Tsyba, N N, Turkina, A G, Chelysheva, E Yu, Nemchenko, I S, Kovrigina, A M, Obukhova, T N, Urnova, E S, Kuzmina, L A, Savchenko, V G

“…Myeloproliferative disease associated with FGFR1 rearrangement (8p11), which is included in the 2008 WHO Classification of Myeloid Neoplasms, is a rare and…”
Get full text

FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy by Nemchenko, I S, Turkina, A G, Chelysheva, E Yu, Galstyan, G M, Kovrigina, A M, Khuazheva, N K, Savchenko, V G

“…The described case of FIP1L1-PDGFRА-positive myeloproliferative disease is characterized by an atypical aggressive course to develop severe specific…”
Get full text

Treatment-free remission in patients with chronic myeloid leukemia: literature review by Petrova, A. N., Chelysheva, E. Yu, Turkina, A. G.

“…Tyrosine kinase inhibitors have radically changed the course of chronic myeloid leukemia, significantly increasing survival and reducing the risk of disease…”
Get full text

Successful use of long-term follow-up in patients with chronic myeloid leukemia with a deep molecular response at reduced doses of 2nd generation tyrosine kinase inhibitors: clinical cases and literature review by Gurianova, M A, Chelysheva, E Y, Shukhov, O A, Turkina, A G

“…Therapy with tyrosine kinase inhibitors (TKI) allows to achieve a deep molecular response in 6070% of patients with chronic myeloid leukemia (CML). According…”
Get full text

Dasatinib treatment of imatinib-resistant and imatinib-intolerant patients with chronic myeloid leukemia in a chronic phase by Vinogradova, O Iu, Turkina, A G, Vorontsova, A V, Chelysheva, E Iu, Gusarova, G A, Kuznetsov, S V, Goriacheva, S R, Sokolova, M A, Abakumov, E M, Stakhina, O V, Domracheva, E V, Misiurin, A V, Khoroshko, N D

“…To analyse resistance to imatinib therapy, efficacy and safety of dasatinib. A total of 18 patients with chronic myeloid leukemia (CML) in a chronic stage…”
Get full text

Therapeutic strategy for chronic myeloid leukemia: possibilities and prospects by Turkina, A G, Chelysheva, E Iu

“…Over the past decade the clinical introduction of agents that directionally blocks the activity of BCR-ABL tumor tyrosine kinase (TK) has changed the prognosis…”
Get full text

Incidence of chronic myeloid leukemia in 6 regions of Russia according to the data of the 2009-2012 population-based study by Kulikov, S M, Vinogradova, O Iu, Chelysheva, E Iu, Tishchenko, I A, Galaĭko, M A, Lazareva, O V, Senderova, O M, Pepeliaeva, V M, Meresiĭ, S V, Luchinin, A S, Ovsepian, V A, Miliutina, G I, Gavrilova, L V, Avdeeva, L B, Neverova, A L, Turkina, A G

“…To assess the main epidemiological characteristics of chronic myeloid leukemia (CML) in the Russian Federation. A planned epidemiological prospective study was…”
Get full text

The comparative analysis of BCR-ABL/ABL detection by real-time quantitative PCR and automated GeneXpert Dx System in chronic myeloid leukemia patients with major and complete molecular response by S. A. Smirnikhina, G. A. Tsaur, E. Yu. Chelysheva, Yu. A. Yakovleva, A. V. Lavrov, A. O. Аbdullaev, N. V. Bederak, O. A. Shukhov, A. G. Solodovnikov, A. M. Popov, E. P. Adilgereeva, L. G. Fechina, A. G. Turkina, S. I. Kutsev

“…Key words: chronic myeloid leukemia, BCR-ABL expression, automated GeneXpert method…”
Get full text

The comparative analysis of BCR-ABL/ABL detection by real-time quantitative PCR and automated GeneXpert Dx System in chronic myeloid leukemia patients with major and complete molecular response by S. A. Smirnikhina, G. A. Tsaur, E. Yu. Chelysheva, Yu. A. Yakovleva, A. V. Lavrov, A. O. Аbdullaev, N. V. Bederak, O. A. Shukhov, A. G. Solodovnikov, A. M. Popov, E. P. Adilgereeva, L. G. Fechina, A. G. Turkina, S. I. Kutsev

“…Key words: chronic myeloid leukemia, BCR-ABL expression, automated GeneXpert method…”
Get full text

Influence of different chromosomal abnormalities in Ph-positive bone marrow cells on the chronic myeloid leukemia course during tyrosine kinase inhibitors therapy by O. Yu. Vinogradova, E. A. Aseeva, A. V. Vorontsova, A. G. Turkina, A. L. Neverova, O. V. Lazareva, E. Yu. Chelysheva, G. A. Gusarova, T. I. Kolosheinova, L. Yu. Kolosova, S. R. Goryacheva, M. V. Vakhrusheva, S. M. Kulikov, I. A. Tishchenko, L. V. Dyachenko, A. I. Udovichenko, G. A. Alimova, E. V. Kleina, L. A. Grebenyuk, M. L. Konnova, S. Yu. Smirnova, N. D. Khoroshko, E. V. Domracheva

“…The additional molecular and chromosomal abnormalities (ACA) in Phositive cells usually considered as a genetic marker of chronic myeloid leukemia (CML)…”
Get full text

Influence of different chromosomal abnormalities in Ph-positive bone marrow cells on the chronic myeloid leukemia course during tyrosine kinase inhibitors therapy by O. Yu. Vinogradova, E. A. Aseeva, A. V. Vorontsova, A. G. Turkina, A. L. Neverova, O. V. Lazareva, E. Yu. Chelysheva, G. A. Gusarova, T. I. Kolosheinova, L. Yu. Kolosova, S. R. Goryacheva, M. V. Vakhrusheva, S. M. Kulikov, I. A. Tishchenko, L. V. Dyachenko, A. I. Udovichenko, G. A. Alimova, E. V. Kleina, L. A. Grebenyuk, M. L. Konnova, S. Yu. Smirnova, N. D. Khoroshko, E. V. Domracheva

“…The additional molecular and chromosomal abnormalities (ACA) in Phositive cells usually considered as a genetic marker of chronic myeloid leukemia (CML)…”
Get full text

5th International Symposium on Leukemia and Lymphoma12-15 March 2003Vrije Universiteit, Amsterdam, The Netherlands by Zakharova, E S, Inshakov, A N, Turkina, A G, Kruglov, S S, Dyagileva, O A, Drouzhkova, G A, Nemchenko, I S, Chelysheva, E Yu, Baryshnikov, A Yu

“…ORGANIZING COMMITTEE::G.J.L. Kaspers, VU University Medical Center, Amsterdam, The NetherlandsJ.J.M. van Dongen, Erasmus MC, Rotterdam, The NetherlandsM…”
Get full text

Trisomy of chromosome 8 in Ph-negative cells of the bone marrow in patients with chronic myeloid leukemia treated with inhibitors of BCR-ABL tyrosinkinases by Anna Grigor'evna Turkina, Elena Vasil'evna Domracheva, Aleksandra Valer'evna Vorontsova, Elena Aleksandrovna Aseeva, Ol'ga Yur'evna Vinogradova, Ol'ga Veniaminovna Stakhina, Galina Anatol'evna Gusarova, Ol'ga Arkad'evna Dyagileva, Elena Aleksandrovna Semenova, Marina Vasil'evna Vakhrusheva, Tamara Ivanovna Kolosheynova, Evgeniy Mikhaylovich Abakumov, Ekaterina Yur'evna Chelysheva, Svetlana Rudol'fovna Goryacheva, Tat'yana Vladimirovna Ivanova, Elena Stanislavovna Zakharova, Lyubov' Yur'evna Kolosova, Adel' Vladimirovna Zakharova, Irina Nikolaevna Naumova, Larisa Vladimirovna Dyachenko, Sergey Mikhaylovich Kulikov, Lidiya Grigor'evna Kovaleva, Nina Dmitrievna Khoroshko, A G Turkina, E V Domracheva, A V Vorontsova, E A Aseeva, O Yu Vinogradova, O V Stakhina, G A Gusarova, O A Dyagileva, E A Semenova, M V Vakhrusheva, T I Kolosheinova, E M Abakumov, E Yu Chelysheva, S R Goryacheva, T V Ivanova, E S Zakharova, L Yu Kolosova, A V Zakharova, I N Naumova, L V Dyachenko, S M Kulikov, L G Kovaleva, N D Khoroshko

“…Aim. To analyse clinical implications of chromosome 8 trisomy in Ph-negative cells of the bone marrow in patients with chronic myeloid leukemia (CML) treated…”
Get full text

Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction by Chelysheva, E Iu, Turkina, A G, Misiurin, A V, Aksenova, E V, Domracheva, E V, Zakharova, A V, Khoroshko, N D

“…To quantitatively determine minimal residual disease (MRD) by real-time polymerase chain reaction (PCR) in patients with a chronic phase (CP) of chronic…”
Get more information

Recovery of polyclonial hemopoiesis in females with chronic myeloid leukemia with a complete cytogenetic response by Ermakova, T A, Chelysheva, E Iu, Turkina, A G, Sokolova, M A, Zakharova, A V, Danil'cheva, E S, Misiurin, A V

“…To study feasibility of hemopoiesis clonality determination in assessment of remission completeness in patients with chronic myeloid leukemia (CML) using…”
Get more information

Opyt GNTs RAMN po primeneniyunilotiniba (Tasigna) u bol'nykhv khronicheskoy faze khronicheskogomieloleykoza pri neudache terapiiimatinibom by G A Gusarova, A G Turkina, E V Domracheva, L Yu Tikhonova, M O Egorova, T I Kolosheynova, O V Stakhina, I S Nemchenko, M V Vakhrusheva, E Yu Chelysheva, E S Zakharova, S R Goryacheva, M A Sokolova, S V Kuznetsov, N A Afanas'eva, N D Khoroshko

Get full text

Cytogenetic response as a marker of efficacy of chronic myeloid leukemia therapy with a BCR-ABL thyrosine kinase inhibitor glivek by Turkina, A G, Kruglov, S S, Druzhkova, G A, Domracheva, E V, Zakharova, A V, Vinogradova, O Iu, Sysoeva, E P, Diachenko, L V, Chelysheva, E Iu, Zakharova, E S, Abakumov, E M, Kolosheĭnova, T I, Kolosova, L Iu, Ivanova, T V, Zhuravlev, V S, Nemchenko, I S, Zingerman, B V, Kurova, E S, Triputen', N Z, Loriia, S S, Kovaleva, L G, Khoroshko, N D

“…Clinical practice with the drug glivek (imatinibe mesilate, ST1571) blocking activity of oncoprotein p210 shows that a cytogenetic response can be reached in…”
Get more information